Ellen C. Havenaar

Selective liver targeting of antivirals by recombinant chylomicrons — a new therapeutic approach to hepatitis B

Patrick C.N. Rensen, M.C.M. van Dijk, Ellen C. Havenaar et al. · Nature Medicine · 1995 · 146 citations

Hepatic Disorders, Hepatology, New Therapeutic Approach +14

Inflammation-induced expression of sialyl Lewisx is not restricted to α1-acid glycoprotein but also occurs to a lesser extent on α1-antichymotrypsin and haptoglobin

Els C.M. Brinkman-Van der Linden, Patricia F. de Haan, Ellen C. Havenaar et al. · Glycoconjugate Journal · 1998 · 92 citations

Oral estrogen treatment induces a decrease in expression of sialyl Lewis x on α₁ glycoprotein in females and male-to-female transsexuals

Els C.M. Brinkman-Van der Linden, Ellen C. Havenaar, Esther C. R. van Ommen et al. · Glycobiology · 1996 · 63 citations · Full text

Glycosylation of .ALPHA.1-Acid Glycoprotein(Orosomucoid) in Health and Disease: Occurrence, Regulation and Possible Funtional Implications.

Willem van Dijk, Els C.M. Brinkman-Van der Linden, Ellen C. Havenaar · Trends in Glycoscience and Glycotechnology · 1998 · 48 citations · Full text

Glycoproteomics, Protein Glycosylation, Mathematical Programming +11

Severe rheumatoid arthritis prohibits the pregnancy-induced decrease in α3-fucosylation of α1-acid glycoprotein

Ellen C. Havenaar, John S. Axford, Els C.M. Brinkman-Van der Linden et al. · Glycoconjugate Journal · 1998 · 38 citations